Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility testing methods | Zendy

Kévin Alexandre | Zendy; Mathilde Réveillon-Istin | Zendy; R. Fabré | Zendy; V. Delbos | Zendy; Manuel Etienne | Zendy; Martine PestelCaron | Zendy; Sandrine Dahyot | Zendy; François Caron | Zendy

Open Access

Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility testing methods

Author(s) -

Kévin Alexandre,

Mathilde Réveillon-Istin,

R. Fabré,

V. Delbos,

Manuel Etienne,

Martine PestelCaron,

Sandrine Dahyot,

François Caron

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky101

Subject(s) - etest , enterobacteriaceae , agar dilution , microbiology and biotechnology , antibiotics , carbapenem resistant enterobacteriaceae , medicine , biology , minimum inhibitory concentration , escherichia coli , biochemistry , gene

Temocillin is an old 'revived' antibiotic that may play an important role in the treatment of febrile urinary tract infection (UTI). Data regarding its activity against current Enterobacteriaceae isolates as well as the performance of routine susceptibility testing methods are, however, scarce.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research